Transaction #2565 · Form 4 · 0001213900-25-102764
CorMedix Inc. · Purchase · Common Stock
CorMedix Inc. · Transacted October 23, 2025 · Filed October 27, 2025
What does this filing report?
An SEC Form 4 filing for CorMedix Inc. records a purchase involving Common Stock on October 23, 2025. The reported quantity was 25,000. The filing date is October 27, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CorMedix Inc.
- Company CIK
- 0001410098
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 25,000
- Reported price
- 11.02 · See footnotes
- Reference value
- 275,500
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 201,034
- Ownership description
- Not reported
- SEC acceptance time
- Oct 27, 2025, 9:30 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Kaplan Myron ↗
Director
CIK 0001672645
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- F2
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.